Marex Earnings per Diluted Share from 2010 to 2024
| MRX Stock | 29.28 0.13 0.45% |
Check Marex Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Marex Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 23 M, Total Revenue of 1.2 B or Gross Profit of 631.5 M, as well as many indicators such as Price To Sales Ratio of 0.69, Dividend Yield of 0.0446 or PTB Ratio of 2.62. Marex financial statements analysis is a perfect complement when working with Marex Group Valuation or Volatility modules.
Marex | Earnings per Diluted Share |
About Marex Group Financial Statements
Marex Group investors use historical fundamental indicators, such as Marex Group's Earnings per Diluted Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Marex Group. Please read more on our technical analysis and fundamental analysis pages.
Medicis Pharmaceutical Corporationration, a specialty pharmaceutical company, engages in the development and marketing of various solutions for the treatment of dermatological and aesthetic conditions in the United States and Canada.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Marex Stock Analysis
When running Marex Group's price analysis, check to measure Marex Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marex Group is operating at the current time. Most of Marex Group's value examination focuses on studying past and present price action to predict the probability of Marex Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marex Group's price. Additionally, you may evaluate how the addition of Marex Group to your portfolios can decrease your overall portfolio volatility.